3,501
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer

, , , , , , & ORCID Icon show all
Pages 4828-4840 | Received 24 Mar 2021, Accepted 06 Jul 2021, Published online: 04 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yuxi Gu, Shouyi Tang, Zhen Wang, Luyao Cai, Haosen Lian, Yingqiang Shen & Yu Zhou. (2021) A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers. Bioengineered 12:1, pages 6166-6185.
Read now

Articles from other publishers (13)

Jun Xie, Li Zhu, Xutao Yang, Fengfei Yu, Bingfu Fan, Yibo Wu, Zonglang Zhou, Weiqiang Lin & Yi Yang. (2024) Combination of theoretical analysis and experiments: Exploring the role of PLA2G7 in human cancers, including renal cancer. Heliyon 10:6, pages e27906.
Crossref
Jianming Shao, Randall J. Olsen, Saro Kasparian, Chuan He, Eric H. Bernicker & Zejuan Li. (2024) Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis. Cells 13:4, pages 298.
Crossref
Arya Moftakhar, Sajad Najafi, Omid Anbiyaee, Maryam Farzaneh & Seyed Esmaeil Khoshnam. (2024) Functional Roles of the lncRNA MALAT1 in Glioma. Current Cancer Therapy Reviews 20:2, pages 166-176.
Crossref
Smita Jha & William F Simonds. (2023) Molecular and Clinical Spectrum of Primary Hyperparathyroidism. Endocrine Reviews 44:5, pages 779-818.
Crossref
Ying Yang, Yu-Mei Zhang, Yan Wang, Kui Liu, Si-Yuan Cui, Ya-Qin Luo, Wei Zheng, Jie Xu, Wei Duan & Jing-Yi Wang. (2023) Genome-wide identification of aberrant alternative splicing and RNA-binding protein regulators in acute myeloid leukaemia which may contribute to immune microenvironment remodelling. Carcinogenesis 44:5, pages 418-425.
Crossref
Jiatong Ding, Xunhui Ji, Lanqi Liu, De-Zhi Chen, Nan Luo, Xiao-Ting Yu & Fei Guo. (2023) A prognostic and immunological analysis of 7B-containing Kelch structural domain (KLHDC7B) in pan-cancer: a potential target for immunotherapy and survival. Journal of Cancer Research and Clinical Oncology 149:10, pages 7857-7876.
Crossref
Xingqiu Ruan, Guoliang Cui, Changyu Li & Zhiguang Sun. (2023) Pan-Cancer Analysis Reveals PPRC1 as a Novel Prognostic Biomarker in Ovarian Cancer and Hepatocellular Carcinoma. Medicina 59:4, pages 784.
Crossref
Shengji Cao, Sitong Xiao, Jingyang Zhang & Shijun Li. (2023) Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming. Frontiers in Endocrinology 14.
Crossref
Zonglang Zhou, Bingfu Fan, Hongrong Cheng, Ming Wang, Jun Xie, Mingyuan Zou & Yi Yang. (2022) A Systematic Analysis of the Role of Unc-5 Netrin Receptor A (UNC5A) in Human Cancers. Biomolecules 12:12, pages 1826.
Crossref
Pingan Chang, Shenglan Chen, Xiumei Chang, Jiaxi Zhu, Qingsheng Tang & Limin Ma. (2022) EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms. European Journal of Medical Research 27:1.
Crossref
Wencong Ding, Biyi Li, Yuan Zhang, Liu He & Junwei Su. (2022) A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma. Frontiers in Genetics 13.
Crossref
Jinhui Liu, Guoliang Cui, Shuning Shen, Feng Gao, Hongjun Zhu & Yinghua Xu. (2022) Establishing a Prognostic Signature Based on Epithelial–Mesenchymal Transition-Related Genes for Endometrial Cancer Patients. Frontiers in Immunology 12.
Crossref
Qi Hu, Mingyue Gao, Du Zhang, Bingfeng Leng, Junwen Wang, Qian Liu, Shuangyan He, Wenling Zhi & Zhijun Zhou. (2021) De novo assembly and transcriptome characterization: Novel insights into the mechanisms of primary ovarian cancer in Microtus fortis . Molecular Medicine Reports 25:2.
Crossref